Olmin 20 LN Tablet
By Olmin LN
Rx
10 Tablet in a Strip

Composition
Olmesartan Medoxomil(20mg) + Cilnidipine(10mg)

Manufacturer - Eris Lifesciences Ltd
8th Floor, Commerce House IV, Prahladnagar, Ahmedabad – 380015 Gujarat, India

Expires on or after
September, 2026

liver
When using Olmin 20 LN Tablet, it is important to be cautious if you have severe liver disease. In such cases, it may be necessary to adjust the dose of the tablet. It is advisable to consult your doctor before using this medication. However, for individuals with mild liver disease, no dose adjustment is typically needed. If you have any concerns about using Olmin 20 LN Tablet in relation to your liver health, it is best to seek guidance from your healthcare provider to ensure safe usage.

kidney
Olmin 20 LN Tablet may need dose adjustment for patients with severe kidney disease. Regular blood pressure monitoring is recommended. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Olmin 20 LN Tablet.

driving
Caution for Driving Olmin 20 LN Tablet can reduce alertness, impact vision, and cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
During pregnancy, Olmin 20 LN Tablet should be avoided as it poses a definite risk to the developing baby. Consult your doctor before use, as it may only be prescribed in life-threatening situations with careful consideration of the benefits outweighing potential risks.

breastfeeding
Information on the safety of Olmin 20 LN Tablet during breastfeeding is not available. It is advisable to consult your doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | CARDIAC |
Action Class | - |
₹165.46
Inclusive of all taxes
Content verified by

Dr. Preeti Kumar
MBBS, DGO - Obstetrics and Gynaecology, DNB - Obstetrics and Gynaecology
Last update on 01-Oct-2024